Developmental changes in hepatic esterase activity towards chloramphenicol succinate and its Michaelis-Menten

Related Experiment Videos

Developmental Pharmacology and Therapeutics
|January 1, 1984
PubMed

Insights

Hepatic esterase activity toward chloramphenicol succinate shows significant postnatal development. Enzyme activity and Vmax values increase with age, indicating the liver

Area of Science:

  • Pharmacology
  • Biochemistry
  • Human Physiology

Background:

  • Chloramphenicol succinate is a prodrug requiring hydrolysis for activation.
  • Esterase enzymes are crucial for drug metabolism, but their developmental profiles are not fully understood.

Purpose of the Study:

  • To investigate the developmental changes in hepatic esterase activity towards chloramphenicol succinate in humans.
  • To compare esterase activity across different human age groups and organs.

Main Methods:

  • Human tissue samples were collected from fetuses, neonates, infants, and adults.
  • Hepatic esterase activity was measured using chloramphenicol succinate as a substrate.
  • Kinetic parameters (Km and Vmax) were determined for liver, lung, and kidney tissues.

Main Results:

  • Esterase activity was significantly lower in fetal and neonatal tissues compared to infants and adults.
  • Km values were consistent across age groups within each organ but varied between organs (renal Km higher).
  • Vmax values demonstrated a clear developmental increase in all investigated organs.

Conclusions:

  • Hepatic esterase activity towards chloramphenicol succinate exhibits significant postnatal development.
  • The liver plays a primary role in chloramphenicol succinate hydrolysis, especially considering its weight.
  • Understanding these developmental changes is crucial for optimizing chloramphenicol-based therapies in pediatric populations.

Related Concept Videos